Pamela Reilly Contag
Vorstandsvorsitzender bei Cygnet, Inc.
Profil
Pamela Reilly Contag is the founder.
She founded Cobalt Technologies, Inc. in 2005 and served as the Chief Technology Officer from 2006 to 2012.
She also founded Xenogen Corp.
in 1995 and was the President from 1995 to 2006.
Dr. Contag is also the founder of ConcentRx Corp., BioEclipse Therapeutics, Inc...Dr. Contag's current job is as the Chief Executive Officer at Cygnet, Inc.Dr. Contag's former jobs include being a Director at Delcath Systems, Inc., an Independent Director at Pro Farm Group, Inc. from 2014 to 2016, and a Principal at Stanford University.
Dr. Contag's education includes an undergraduate degree from St. Catherine University (Minnesota) and a doctorate degree from the University of Minnesota Medical School, which she received in 1989.
Aktive Positionen von Pamela Reilly Contag
| Unternehmen | Position | Beginn |
|---|---|---|
Cygnet, Inc.
 Cygnet, Inc. Miscellaneous Commercial ServicesCommercial Services Cygnet, Inc. provides training, support, staffing, and operational strategy consulting services to the pharmaceutical and healthcare sectors. The private company is based in Somerset, NJ. The CEO of the company is Pamela Reilly Contag. | Vorstandsvorsitzender | - |
BioEclipse Therapeutics, Inc.
 BioEclipse Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology BioEclipse Therapeutics, Inc. engages in the development of curative immune-oncology therapeutics for patient with cancer. Its patented immunotherapy is the CRX-100, which delivers potentially curative treatments to patients over a broad range of tumor type. The company was founded by Pamela R. Contag, Christopher Contag, and Robert Negrin and is headquartered in San Francisco, CA. | Gründer | - |
Ehemalige bekannte Positionen von Pamela Reilly Contag
| Unternehmen | Position | Ende |
|---|---|---|
| MARRONE BIO INNOVATIONS, INC. | Direktor/Vorstandsmitglied | 25.05.2016 |
Xenogen Corp.
 Xenogen Corp. Medical SpecialtiesHealth Technology Xenogen Corp. provides real time in-vivo imaging services and genetic modification technologies. Its products and technologies include an imaging system, software, and biological materials. Its solutions are designed to improve discovery and pre-clinical research in multiple therapeutic areas. The company was founded by Pamela Reilly Contag and Christopher H. Contag in 1995 and is headquartered in Alameda, CA. | Gründer | 01.01.2006 |
| ConcentRx Corp. | Vorstandsvorsitzender | - |
Cobalt Technologies, Inc.
 Cobalt Technologies, Inc. Chemicals: SpecialtyProcess Industries Cobalt Technologies, Inc. develops, produces and commercializes bio-based chemicals. The firm engages in the creation of biobutanol using various cellulosic feedstocks, which include corn cobs, treetops and limbs and dead pine trees from pine beetles. It extracts fermentable sugars from biomass and converts them directly into bio n-butanol, which is an ingredient in coatings, paints, adhesives, sealants, inks and other solvent products. The company was founded by Pamela Reilly Contag in 2005 and is headquartered in Mountain View, CA. | Gründer | - |
| DELCATH SYSTEMS, INC. | Direktor/Vorstandsmitglied | - |
Ausbildung von Pamela Reilly Contag
| St. Catherine University (Minnesota) | Undergraduate Degree |
| University of Minnesota Medical School | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| DELCATH SYSTEMS, INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Xenogen Corp.
Xenogen Corp. Medical SpecialtiesHealth Technology Xenogen Corp. provides real time in-vivo imaging services and genetic modification technologies. Its products and technologies include an imaging system, software, and biological materials. Its solutions are designed to improve discovery and pre-clinical research in multiple therapeutic areas. The company was founded by Pamela Reilly Contag and Christopher H. Contag in 1995 and is headquartered in Alameda, CA. | Health Technology |
Cobalt Technologies, Inc.
Cobalt Technologies, Inc. Chemicals: SpecialtyProcess Industries Cobalt Technologies, Inc. develops, produces and commercializes bio-based chemicals. The firm engages in the creation of biobutanol using various cellulosic feedstocks, which include corn cobs, treetops and limbs and dead pine trees from pine beetles. It extracts fermentable sugars from biomass and converts them directly into bio n-butanol, which is an ingredient in coatings, paints, adhesives, sealants, inks and other solvent products. The company was founded by Pamela Reilly Contag in 2005 and is headquartered in Mountain View, CA. | Process Industries |
| ConcentRx Corp. | |
Pro Farm Group, Inc.
 Pro Farm Group, Inc. Chemicals: AgriculturalProcess Industries Pro Farm Group, Inc. engages in the provision of biological-based solutions for agricultural crops, turf protection, seed treatment, plant health and waterway systems. Its products include Grandevo Insecticide, Majestene Nematicide, Regalia Fungicide, Stargus Fungicide, Venerate Insecticide, Amplitude Fungicide, Regalia Rx Plant Health, Zelto Nematicide, Zequanox Molluscicide and Haven. The company was founded by Pamela G. Marrone on June 15, 2006 and is headquartered in Raleigh, NC. | Process Industries |
Cygnet, Inc.
Cygnet, Inc. Miscellaneous Commercial ServicesCommercial Services Cygnet, Inc. provides training, support, staffing, and operational strategy consulting services to the pharmaceutical and healthcare sectors. The private company is based in Somerset, NJ. The CEO of the company is Pamela Reilly Contag. | Commercial Services |
BioEclipse Therapeutics, Inc.
BioEclipse Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology BioEclipse Therapeutics, Inc. engages in the development of curative immune-oncology therapeutics for patient with cancer. Its patented immunotherapy is the CRX-100, which delivers potentially curative treatments to patients over a broad range of tumor type. The company was founded by Pamela R. Contag, Christopher Contag, and Robert Negrin and is headquartered in San Francisco, CA. | Health Technology |
